These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 33629768)
21. Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia. Lin H; Magrane J; Rattelle A; Stepanova A; Galkin A; Clark EM; Dong YN; Halawani SM; Lynch DR Dis Model Mech; 2017 Nov; 10(11):1343-1352. PubMed ID: 29125827 [TBL] [Abstract][Full Text] [Related]
23. Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia. Li L; Voullaire L; Sandi C; Pook MA; Ioannou PA; Delatycki MB; Sarsero JP PLoS One; 2013; 8(2):e55940. PubMed ID: 23418481 [TBL] [Abstract][Full Text] [Related]
24. Structure-function analysis of Friedreich's ataxia mutants reveals determinants of frataxin binding and activation of the Fe-S assembly complex. Bridwell-Rabb J; Winn AM; Barondeau DP Biochemistry; 2011 Aug; 50(33):7265-74. PubMed ID: 21776984 [TBL] [Abstract][Full Text] [Related]
25. Pathophysiogical and therapeutic progress in Friedreich ataxia. Puccio H; Anheim M; Tranchant C Rev Neurol (Paris); 2014 May; 170(5):355-65. PubMed ID: 24792433 [TBL] [Abstract][Full Text] [Related]
26. The in vivo mitochondrial two-step maturation of human frataxin. Schmucker S; Argentini M; Carelle-Calmels N; Martelli A; Puccio H Hum Mol Genet; 2008 Nov; 17(22):3521-31. PubMed ID: 18725397 [TBL] [Abstract][Full Text] [Related]
27. Friedreich's ataxia: past, present and future. Marmolino D Brain Res Rev; 2011 Jun; 67(1-2):311-30. PubMed ID: 21550666 [TBL] [Abstract][Full Text] [Related]
28. Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts. Khonsari H; Schneider M; Al-Mahdawi S; Chianea YG; Themis M; Parris C; Pook MA; Themis M Gene Ther; 2016 Dec; 23(12):846-856. PubMed ID: 27518705 [TBL] [Abstract][Full Text] [Related]
29. Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function. Selak MA; Lyver E; Micklow E; Deutsch EC; Onder O; Selamoglu N; Yager C; Knight S; Carroll M; Daldal F; Dancis A; Lynch DR; Sarry JE Mitochondrion; 2011 Mar; 11(2):342-50. PubMed ID: 21147271 [TBL] [Abstract][Full Text] [Related]
30. Compound heterozygosity for an expanded (GAA) and a (GAAGGA) repeat at FXN locus: from a diagnostic pitfall to potential clues to the pathogenesis of Friedreich ataxia. Santoro M; Perna A; La Rosa P; Petrillo S; Piemonte F; Rossi S; Riso V; Nicoletti TF; Modoni A; Pomponi MG; Chiurazzi P; Silvestri G Neurogenetics; 2020 Oct; 21(4):279-287. PubMed ID: 32638185 [TBL] [Abstract][Full Text] [Related]
31. Cellular, molecular and functional characterisation of YAC transgenic mouse models of Friedreich ataxia. Anjomani Virmouni S; Sandi C; Al-Mahdawi S; Pook MA PLoS One; 2014; 9(9):e107416. PubMed ID: 25198290 [TBL] [Abstract][Full Text] [Related]
32. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures. Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117 [TBL] [Abstract][Full Text] [Related]
33. Epigenetic promoter silencing in Friedreich ataxia is dependent on repeat length. Chutake YK; Lam C; Costello WN; Anderson M; Bidichandani SI Ann Neurol; 2014 Oct; 76(4):522-8. PubMed ID: 25112975 [TBL] [Abstract][Full Text] [Related]
34. Exploring iron-binding to human frataxin and to selected Friedreich ataxia mutants by means of NMR and EPR spectroscopies. Bellanda M; Maso L; Doni D; Bortolus M; De Rosa E; Lunardi F; Alfonsi A; Noguera ME; Herrera MG; Santos J; Carbonera D; Costantini P Biochim Biophys Acta Proteins Proteom; 2019 Nov; 1867(11):140254. PubMed ID: 31344531 [TBL] [Abstract][Full Text] [Related]
36. Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy. Stram AR; Wagner GR; Fogler BD; Pride PM; Hirschey MD; Payne RM PLoS One; 2017; 12(5):e0178354. PubMed ID: 28542596 [TBL] [Abstract][Full Text] [Related]
37. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Rötig A; de Lonlay P; Chretien D; Foury F; Koenig M; Sidi D; Munnich A; Rustin P Nat Genet; 1997 Oct; 17(2):215-7. PubMed ID: 9326946 [TBL] [Abstract][Full Text] [Related]
38. Friedreich Ataxia: From the Eye of a Molecular Biologist. Muthuswamy S; Agarwal S Neurologist; 2015 Sep; 20(3):51-5. PubMed ID: 26375377 [TBL] [Abstract][Full Text] [Related]
39. Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia. Igoillo-Esteve M; Oliveira AF; Cosentino C; Fantuzzi F; Demarez C; Toivonen S; Hu A; Chintawar S; Lopes M; Pachera N; Cai Y; Abdulkarim B; Rai M; Marselli L; Marchetti P; Tariq M; Jonas JC; Boscolo M; Pandolfo M; Eizirik DL; Cnop M JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31877117 [TBL] [Abstract][Full Text] [Related]
40. A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia. Kelly M; Bagnall RD; Peverill RE; Donelan L; Corben L; Delatycki MB; Semsarian C J Mol Cell Cardiol; 2011 Nov; 51(5):848-54. PubMed ID: 21771600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]